Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
McKinsey
UBS
Moodys
Johnson and Johnson
Citi
US Army
Julphar

Generated: July 22, 2018

DrugPatentWatch Database Preview

Abraxis Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for ABRAXIS PHARM, and what generic and branded alternatives to ABRAXIS PHARM drugs are available?

ABRAXIS PHARM has one hundred and thirteen approved drugs.

There is one tentative approval on ABRAXIS PHARM drugs.

Summary for Abraxis Pharm
US Patents:0
Tradenames:63
Ingredients:60
NDAs:113

Drugs and US Patents for Abraxis Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 070649-001 Nov 17, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 088909-001 Feb 7, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm POTASSIUM CHLORIDE potassium chloride INJECTABLE;INJECTION 087787-001 Apr 20, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062604-001 Nov 24, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Merck
Healthtrust
Baxter
Chinese Patent Office
Cipla
Fish and Richardson
Daiichi Sankyo
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.